(Q39017038)

English

Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ.

scientific article published on 10 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ. (English)

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Anne-Marie Cleton-Jansen

9

object named as

Anne-Marie Cleton-Jansen

0 references

11

object named as

Wim Jiskoot

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

R Maarten Egeler

10

object named as

R Maarten Egeler

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Arjan Lankester

12

object named as

Arjan C Lankester

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Marco W Schilham

13

object named as

Marco W Schilham

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Maarten van Tol

8

object named as

Maarten J D van Tol

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

4

object named as

Susy J Santos

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

author name string

Jens H W Pahl

1

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Kitty M C Kwappenberg

2

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Eleni M Varypataki

3

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Marieke L Kuijjer

5

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Susan Mohamed

6

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Juul T Wijnen

7

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Anne-Marie Cleton-Jansen

9

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

publication date

10 March 2014

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Journal of Experimental & Clinical Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

33

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

27

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

https://scigraph.springernature.com/pub.10.1186/1756-9966-33-27

0 references

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

New molecular insights into osteosarcoma targeted therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Macrophage biology in development, homeostasis and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Cancer immunoediting by the innate immune system in the absence of adaptive immunity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Differential macrophage programming in the tumor microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Exploring the full spectrum of macrophage activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Macrophage diversity in renal injury and repair.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Signal integration between IFNgamma and TLR signalling pathways in macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Targeting tumor-associated macrophages as a novel strategy against breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

9 September 2017

Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

14 September 2017

Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

14 September 2017

M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

14 September 2017

Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

14 September 2017

Coley's toxins, tumor necrosis factor and cancer research: a historical perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

14 September 2017

Macrophage activity and clinical immunology. Origin and kinetics of mononuclear phagocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

14 September 2017

Conditioned media from macrophages of M1, but not M2 phenotype, inhibit the proliferation of the colon cancer cell lines HT-29 and CACO-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

17 June 2018

Activation of cytolytic activity in peripheral blood monocytes of renal cancer patients against non-cultured autologous tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

17 June 2018

Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant gamma-interferon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

17 June 2018

Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

17 June 2018

High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

21 August 2018

High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

21 August 2018

Activation of tumoricidal properties in peripheral blood monocytes of patients with colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

21 August 2018

Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-33-27

21 January 2018

II. Contribution to the Knowledge of Sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007518

2 December 2018

Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-33-27

21 January 2018

Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IFN- Enhances Production of Nitric Oxide from Macrophages via a Mechanism That Depends on Nucleotide Oligomerization Domain-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The macrophage as an effector cell

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of murine renal adenocarcinoma by systemic administration of liposomes containing the synthetic macrophage activator CGP 31362 or CGP 19835A in combination with interleukin 2 or gamma-interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ activation of mouse alveolar macrophages by aerosolized liposomal IFN-gamma and muramyl tripeptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergism of recombinant human interferon gamma with liposome-encapsulated muramyl tripeptide in activation of the tumoricidal properties of human monocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor cytotoxicity and interleukin 1 production of blood monocytes of lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24612598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1756-9966-33-27

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39017038&oldid=2165357976"